The latest closing stock price for Viking Therapeutics as of November 20, 2024 is 51.53.
An investor who bought $1,000 worth of Viking Therapeutics stock at the IPO in 2015 would have $4,751 today, roughly 5 times their original investment - a 19.12% compound annual growth rate over 10 years.
The all-time high Viking Therapeutics stock closing price was 94.50 on February 28, 2024.
The Viking Therapeutics 52-week high stock price is 99.41, which is 92.9% above the current share price.
The Viking Therapeutics 52-week low stock price is 11.54, which is 77.6% below the current share price.
The average Viking Therapeutics stock price for the last 52 weeks is 53.57.
An investor who bought $1,000 worth of Viking Therapeutics stock at the IPO in 2015 would have $4,751 today, roughly 5 times their original investment - a 19.12% compound annual growth rate over 10 years.
The all-time high Viking Therapeutics stock closing price was 94.50 on February 28, 2024.
The Viking Therapeutics 52-week high stock price is 99.41, which is 92.9% above the current share price.
The Viking Therapeutics 52-week low stock price is 11.54, which is 77.6% below the current share price.
The average Viking Therapeutics stock price for the last 52 weeks is 53.57.